Brazos Minshew, President of Vancouver’s Biocell Labs (a wholly-owned subsidiary of Abattis Bioceuticals Corp), went to Tulsa, Oklahoma this week to train opinion-leaders on the use of cannabinoids in medicine as part of NuMedica’s “train the trainer” program.
NuMedica is a top-tier distributor of nutraceutical remedies to physicians, pharmacists and other licensed health care providers. Their annual sales meeting is attended by their own sales team, plus physicians, pharmacists, chiropractors and naturopaths from all over North America. This year, the training includes the medical use of phytocannabinoids including CBD that are produced by Biocell Labs, Inc.
At the NuMedica forum, Biocell Labs, Inc. is launching a cannabinoid-rich product designed to address the issues of pain and inflammation. Designed to be legal in all 50 States and 10 Provinces, the phytocannabinoid product will be based in Liposomes to enhance nutrient delivery. Liposome technology is provided through an exclusive licensing agreement with Empirical Labs, Ft. Collins Colorado.
NuMedica’s vast distribution network completes the Abattis supply chain from the growers to the formulators at BioCell Labs, to the processors at Empirical Labs, to the distributors at NuMedica and, finally, to the patients who may benefit the most.
